Senyi L. Deng

Chengdu, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Uncovering ectopic GC-like niches for tumor reactive lymphocyte priming in lung adenocarcinoma using Stereo-XCR-seq.

Uncovering ectopic GC-like niches for tumor reactive lymphocyte priming in lung adenocarcinoma using Stereo-XCR-seq.

Journal: Nature communications
Published: September 29, 2025

A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategies.

A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategies.

Journal: Translational lung cancer research
Published: June 27, 2025

Arachidonic acid-mediated autophagy regulation drives crizotinib resistance in lung cancer: therapeutic opportunities and challenges.

Arachidonic acid-mediated autophagy regulation drives crizotinib resistance in lung cancer: therapeutic opportunities and challenges.

Journal: Translational lung cancer research
Published: May 26, 2025

Nanotechnology-Driven Drug Delivery Systems for Lung Cancer: Computational Advances and Clinical Perspectives.

Nanotechnology-Driven Drug Delivery Systems for Lung Cancer: Computational Advances and Clinical Perspectives.

Journal: Thoracic cancer
Published: April 19, 2025

Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1 + or ALK + non-small cell lung cancer to crizotinib therapy.

Targeting of arachidonic acid-modulated autophagy to enhance the sensitivity of ROS1 + or ALK + non-small cell lung cancer to crizotinib therapy.

Journal: Translational lung cancer research
Published: February 23, 2025

Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study).

Dynamic ctDNA informs whole-course postoperative precise management of NSCLC (LUNGCA study).

Journal: Journal of the National Cancer Institute
Published: September 22, 2024

Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis.

Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis.

Journal: PloS one
Published: August 02, 2024

Development of a Prognostic Risk Model for Esophageal Cancer Based on M0 Macrophage-Related Genes.

Development of a Prognostic Risk Model for Esophageal Cancer Based on M0 Macrophage-Related Genes.

Journal: OncoTargets and therapy
Published: August 01, 2024

Association between postoperative radiotherapy for young-onset nonsmall cell lung cancer and risk of second primary malignancies: comparative study.

Association between postoperative radiotherapy for young-onset nonsmall cell lung cancer and risk of second primary malignancies: comparative study.

Journal: International journal of surgery (London, England)
Published: March 06, 2024

Non-coding RNA and its network in the pathogenesis of Myasthenia Gravis.

Non-coding RNA and its network in the pathogenesis of Myasthenia Gravis.

Journal: Frontiers in molecular biosciences
Published: February 19, 2024

Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer.

Tet methylcytosine dioxygenase 2 (TET2) deficiency elicits EGFR-TKI (tyrosine kinase inhibitors) resistance in non-small cell lung cancer.

Journal: Signal transduction and targeted therapy
Published: July 16, 2023

Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.

Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.

Journal: Oncogene
Published: June 01, 2023
Showing 1-12 of 47

Last Updated: 09/26/2026